S Moradian1, N Voelker2, C Brown3, G Liu4, D Howell5,6. 1. Psychosocial Oncology, Ontario Cancer Institute, University of Toronto, Toronto, Canada. 2. University of Waterloo, Waterloo, Canada. 3. University Health Network, Toronto, Canada. 4. Ontario Cancer Institute, Princess Margaret Cancer Care, University of Toronto, Toronto, Canada. 5. Psychosocial Oncology, Ontario Cancer Institute, University of Toronto, Toronto, Canada. doris.howell@uhn.ca. 6. Princess Margaret Cancer Care, 610 University Avenue, Toronto, M5G 2M9, Canada. doris.howell@uhn.ca.
Abstract
PURPOSE: The aims of this review were to (1) examine the effectiveness of Internet-based interventions on cancer chemotherapy-related physical symptoms (severity and/or distress) and health-related quality of life (HRQOL) outcomes and (2) identify the design elements and processes for implementing these interventions in oncology practices. METHODS: A systematic review was performed. The Cochrane Database of Systematic Reviews, and Cochrane Central Register of Controlled Trials, EMBASE, MEDLINE, CINAHL, and PsycINFO were searched for studies dating from January 2000 through to October 2016. Based on pre-determined selection criteria, data was extracted from eligible studies. Methodological quality of studies was assessed using an adapted version of the Cochrane Collaboration Back Review Group checklist. RESULTS: The literature search yielded 1766 studies of which only six RCTs fulfilled the eligibility criteria. Although the content, duration, and frequency of interventions varied considerably across studies, commonly used elements included tailored information, education, self-management support, and communication with clinicians. Five studies measured symptom distress and four of them reported statistically significant differences between study groups. Of the three studies that measured HRQOL, two reported improvement (or no deterioration over time) for the intervention group. However, several methodological issues including high attrition rates, poor adherence to interventions, and use of non-validated measures affect confidence in the strength of evidence. CONCLUSION: Despite the evidence in support of using the Internet as a worthwhile tool for effective patient engagement and self-management of chemotherapy-related symptoms outside clinic visits, methodological limitations in the evidence base require further well-planned and quality research.
PURPOSE: The aims of this review were to (1) examine the effectiveness of Internet-based interventions on cancer chemotherapy-related physical symptoms (severity and/or distress) and health-related quality of life (HRQOL) outcomes and (2) identify the design elements and processes for implementing these interventions in oncology practices. METHODS: A systematic review was performed. The Cochrane Database of Systematic Reviews, and Cochrane Central Register of Controlled Trials, EMBASE, MEDLINE, CINAHL, and PsycINFO were searched for studies dating from January 2000 through to October 2016. Based on pre-determined selection criteria, data was extracted from eligible studies. Methodological quality of studies was assessed using an adapted version of the Cochrane Collaboration Back Review Group checklist. RESULTS: The literature search yielded 1766 studies of which only six RCTs fulfilled the eligibility criteria. Although the content, duration, and frequency of interventions varied considerably across studies, commonly used elements included tailored information, education, self-management support, and communication with clinicians. Five studies measured symptom distress and four of them reported statistically significant differences between study groups. Of the three studies that measured HRQOL, two reported improvement (or no deterioration over time) for the intervention group. However, several methodological issues including high attrition rates, poor adherence to interventions, and use of non-validated measures affect confidence in the strength of evidence. CONCLUSION: Despite the evidence in support of using the Internet as a worthwhile tool for effective patient engagement and self-management of chemotherapy-related symptoms outside clinic visits, methodological limitations in the evidence base require further well-planned and quality research.
Authors: Katherine S Button; John P A Ioannidis; Claire Mokrysz; Brian A Nosek; Jonathan Flint; Emma S J Robinson; Marcus R Munafò Journal: Nat Rev Neurosci Date: 2013-04-10 Impact factor: 34.870
Authors: Tracey E Barnett; Neale R Chumbler; W Bruce Vogel; Rebecca J Beyth; Haijing Qin; Rita Kobb Journal: Am J Manag Care Date: 2006-08 Impact factor: 2.229
Authors: Elin Børøsund; Milada Cvancarova; Shirley M Moore; Mirjam Ekstedt; Cornelia M Ruland Journal: J Med Internet Res Date: 2014-12-18 Impact factor: 5.428
Authors: Anna Cox; Grace Lucas; Afrodita Marcu; Marianne Piano; Wendy Grosvenor; Freda Mold; Roma Maguire; Emma Ream Journal: J Med Internet Res Date: 2017-01-09 Impact factor: 5.428
Authors: Elin Børøsund; Milada Cvancarova; Mirjam Ekstedt; Shirley M Moore; Cornelia M Ruland Journal: J Med Internet Res Date: 2013-03-01 Impact factor: 5.428
Authors: Nicol Nijland; Julia van Gemert-Pijnen; Henk Boer; Michaël F Steehouder; Erwin R Seydel Journal: J Med Internet Res Date: 2008-05-15 Impact factor: 5.428
Authors: Frank J Penedo; Laura B Oswald; Joshua P Kronenfeld; Sofia F Garcia; David Cella; Betina Yanez Journal: Lancet Oncol Date: 2020-05 Impact factor: 41.316
Authors: Roma Maguire; Lisa McCann; Grigorios Kotronoulas; Nora Kearney; Emma Ream; Jo Armes; Elisabeth Patiraki; Eileen Furlong; Patricia Fox; Alexander Gaiger; Paul McCrone; Geir Berg; Christine Miaskowkski; Antonella Cardone; Dawn Orr; Adrian Flowerday; Stylianos Katsaragakis; Andrew Darley; Simone Lubowitzki; Jenny Harris; Simon Skene; Morven Miller; Margaret Moore; Liane Lewis; Nicosha DeSouza; Peter T Donnan Journal: BMJ Date: 2021-07-21
Authors: Marie-Therése Crafoord; Maria Fjell; Kay Sundberg; Marie Nilsson; Ann Langius-Eklöf Journal: J Med Internet Res Date: 2020-08-10 Impact factor: 5.428
Authors: Sewit Teckie; Jeffrey Solomon; Karthik Kadapa; Keisy Sanchez; David Orner; Dennis Kraus; Dev P Kamdar; Lucio Pereira; Douglas Frank; Michael Diefenbach Journal: JMIR Form Res Date: 2021-03-19
Authors: Karoliina Paalimäki-Paakki; Mari Virtanen; Anja Henner; Miika T Nieminen; Maria Kääriäinen Journal: J Med Internet Res Date: 2022-01-06 Impact factor: 5.428
Authors: Elizabeth J Siembida; Bryce B Reeve; Brad J Zebrack; Mallory A Snyder; John M Salsman Journal: Psychooncology Date: 2020-10-30 Impact factor: 3.894
Authors: Christina Sauer; Jürgen Krauß; Dirk Jäger; Stefanie Zschäbitz; Georg Martin Haag; Thomas Walle; Simeon Sauer; Senta Kiermeier; Hans-Christoph Friederich; Imad Maatouk Journal: BMJ Open Date: 2021-07-19 Impact factor: 2.692